(Q27027920)

D. A. D'Alessio

series ordinal

2

1 reference

language of work or name

1 reference

April 2015

1 reference

published in

Physiological Reviews

1 reference

volume

95

1 reference

issue

2

1 reference

page(s)

513-48

1 reference

The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway

cites work

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Deoxycholate is an important releaser of peptide YY and enteroglucagon from the human colon

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The cephalic insulin response to meal ingestion in humans is dependent on both cholinergic and noncholinergic mechanisms and is important for postprandial glycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Inhibition of dipeptidyl peptidase-4 reduces glycemia, sustains insulin levels, and reduces glucagon levels in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

GLP-1 receptor agonists and DPP-4 inhibitors in the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Autonomic regulation of islet hormone secretion--implications for health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Benefits and limitations of reducing glucagon action for the treatment of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Dual elimination of the glucagon and GLP-1 receptors in mice reveals plasticity in the incretin axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Improved glycemic control enhances the incretin effect in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Muscarinic receptors control postprandial release of glucagon-like peptide-1: in vivo and in vitro studies in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The glucagon-like peptide-1 receptor regulates endogenous glucose production and muscle glucose uptake independent of its incretin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Biology of incretins: GLP-1 and GIP

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucose-dependent regulation of gamma-aminobutyric acid (GABA A) receptor expression in mouse pancreatic islet alpha-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Intraislet hyperinsulinemia prevents the glucagon response to hypoglycemia despite an intact autonomic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Role of hyperglucagonemia in maintenance of increased rates of hepatic glucose output in type II diabetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

GLP-1 and energy balance: an integrated model of short-term and long-term control

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The glucagon-miniglucagon interplay: a new level in the metabolic regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Hepatic-portal vein infusions of glucagon-like peptide-1 reduce meal size and increase c-Fos expression in the nucleus tractus solitarii, area postrema and central nucleus of the amygdala in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Hepatic energy state is regulated by glucagon receptor signaling in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

RETRACTED: Hepatic glucagon action is essential for exercise-induced reversal of mouse fatty liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon in physiological concentrations stimulates brown fat thermogenesis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Unique arrangement of alpha- and beta-cells in human islets of Langerhans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Alterations in energy balance following exenatide administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Role of glucagon in maintenance of euglycemia in fed and fasted rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Direct and indirect mechanisms regulating secretion of glucagon-like peptide-1 and glucagon-like peptide-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Control of glucagon-like immunoreactive peptide secretion from fetal rat intestinal cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Metabolic/bariatric surgery Worldwide 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Cytosolic phosphoenolpyruvate carboxykinase does not solely control the rate of hepatic gluconeogenesis in the intact mouse liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Central glucagon-like peptide 1 receptor-induced anorexia requires glucose metabolism-mediated suppression of AMPK and is impaired by central fructose

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The unique cytoarchitecture of human pancreatic islets has implications for islet cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glutamate is a positive autocrine signal for glucagon release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Fuel metabolism in starvation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Paracrine and autocrine interactions in the human islet: more than meets the eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Secretion of glucagon-like peptide-1 in patients with type 2 diabetes mellitus: systematic review and meta-analyses of clinical studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Long-term effects of bariatric surgery on meal disposal and β-cell function in diabetic and nondiabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Pharmacology, physiology, and mechanisms of incretin hormone action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Regulation of gastric emptying rate and its role in nutrient-induced GLP-1 secretion in rats after vertical sleeve gastrectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Absence of the glucagon-like peptide-1 receptor does not affect the metabolic phenotype of mice with liver-specific G(s)α deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Tolbutamide controls glucagon release from mouse islets differently than glucose: involvement of K(ATP) channels from both α-cells and δ-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The role of the Wnt signaling pathway in incretin hormone production and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

A role for intestinal endocrine cell-expressed g protein-coupled receptor 119 in glycemic control by enhancing glucagon-like Peptide-1 and glucose-dependent insulinotropic Peptide release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Insulin reciprocally regulates glucagon secretion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Heterozygous mutations causing partial prohormone convertase 1 deficiency contribute to human obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Fasting and postprandial concentrations of GLP-1 in intestinal lymph and portal plasma: evidence for selective release of GLP-1 in the lymph system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The role of dysregulated glucagon secretion in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Abnormal glucose tolerance and insulin secretion in pancreas-specific Tcf7l2-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Miniglucagon (glucagon 19-29): a novel regulator of the pancreatic islet physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Miniglucagon (glucagon 19-29), a potent and efficient inhibitor of secretagogue-induced insulin release through a Ca2+ pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

GLP-1 response to a mixed meal: what happens 10 years after Roux-en-Y gastric bypass (RYGB)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Optimization of co-agonism at GLP-1 and glucagon receptors to safely maximize weight reduction in DIO-rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

A new glucagon and GLP-1 co-agonist eliminates obesity in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

GLP-1 inhibits and adrenaline stimulates glucagon release by differential modulation of N- and L-type Ca2+ channel-dependent exocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Dipeptidyl peptidase-4 inhibitors for the treatment of type 2 diabetes: comparison, efficacy and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Differential regional metabolism of glucagon in anesthetized pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Hyperglucagonemia and insulin-mediated glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Isolation of mouse pancreatic alpha, beta, duct and acinar populations with cell surface markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The biology of incretin hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Dipeptidyl peptidase-4 inhibition and the treatment of type 2 diabetes: preclinical biology and mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Incretin action in the pancreas: potential promise, possible perils, and pathological pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Alpha cell function in health and disease: influence of glucagon-like peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The role of alpha-cell dysregulation in fasting and postprandial hyperglycemia in type 2 diabetes and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Relationship among brain and blood glucose levels and spontaneous and glucoprivic feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Exendin-4 normalized postcibal glycemic excursions in type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Muscarinic stimulation of pancreatic insulin and glucagon release is abolished in m3 muscarinic acetylcholine receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Gpr40 is expressed in enteroendocrine cells and mediates free fatty acid stimulation of incretin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon-like peptide-1 cells in the gastrointestinal tract and pancreas of rat, pig and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagonoma and the glucagonoma syndrome - cumulative experience with an elusive endocrine tumour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Interleukin-6 regulates pancreatic alpha-cell mass expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Hypothalamic ATP-sensitive K + channels play a key role in sensing hypoglycemia and triggering counterregulatory epinephrine and glucagon responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Small human islets comprised of more β-cells with higher insulin content than large islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Hyperphagia and early-onset obesity due to a novel homozygous missense mutation in prohormone convertase 1/3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Luminal glucose concentrations in the gut under normal conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Altered cAMP and Ca2+ signaling in mouse pancreatic islets with glucagon-like peptide-1 receptor null phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Miniglucagon (MG)-generating endopeptidase, which processes glucagon into MG, is composed of N-arginine dibasic convertase and aminopeptidase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Beta-cell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucose-dependent insulinotropic polypeptide is expressed in pancreatic islet alpha-cells and promotes insulin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Ectopic expression of GIP in pancreatic β-cells maintains enhanced insulin secretion in mice with complete absence of proglucagon-derived peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Pathways and control of ketone body metabolism: on the fringe of lipid biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Defective prohormone processing and altered pancreatic islet morphology in mice lacking active SPC2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Severe defect in proglucagon processing in islet A-cells of prohormone convertase 2 null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Immune challenge and satiety-related activation of both distinct and overlapping neuronal populations in the brainstem indicate parallel pathways for viscerosensory signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Individual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Pancreatic glucagon and postprandial satiety in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Selective hepatic vagotomy blocks pancreatic glucagon's satiety effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Lower blood glucose, hyperglucagonemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Pancreatic beta-cell overexpression of the glucagon receptor gene results in enhanced beta-cell function and mass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Transformation of postingestive glucose responses after deletion of sweet taste receptor subunits or gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Protein hydrolysates stimulate proglucagon gene transcription in intestinal endocrine cells via two elements related to cyclic AMP response element

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Overcoming diabetes-induced hyperglycemia through inhibition of hepatic phosphoenolpyruvate carboxykinase (GTP) with RNAi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon gene expression in the endocrine pancreas: the role of the transcription factor Pax6 in α-cell differentiation, glucagon biosynthesis and secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Intra-islet insulin permits glucose to directly suppress pancreatic A cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Formation of a human β-cell population within pancreatic islets is set early in life

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

ATP-sensitive K+ channel-dependent regulation of glucagon release and electrical activity by glucose in wild-type and SUR1-/- mouse alpha-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon receptor antagonist-mediated improvements in glycemic control are dependent on functional pancreatic GLP-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon's actions are modified by the combination of epinephrine and gluconeogenic precursor infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The metabolic actions of glucagon revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Fibroblast growth factor 21 mediates specific glucagon actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The effects of duodenal peptides on glucagon-like peptide-1 secretion from the ileum. A duodeno--ileal loop?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Neural regulation of glucagon-like peptide-1 secretion in pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The effect of liraglutide, a long-acting glucagon-like peptide 1 derivative, on glycemic control, body composition, and 24-h energy expenditure in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The glucagonostatic and insulinotropic effects of glucagon-like peptide 1 contribute equally to its glucose-lowering action

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Emerging role of AMP-activated protein kinase in endocrine control of metabolism in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Somatostatin secreted by islet delta-cells fulfills multiple roles as a paracrine regulator of islet function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Mice deficient for glucagon gene-derived peptides display normoglycemia and hyperplasia of islet {alpha}-cells but not of intestinal L-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Metabolic impact of glucagon deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Dorsal hindbrain 5'-adenosine monophosphate-activated protein kinase as an intracellular mediator of energy balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

GLP-1 secretion is enhanced directly in the ileum but indirectly in the duodenum by a newly identified potent stimulator, zein hydrolysate, in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Free fatty acids regulate gut incretin glucagon-like peptide-1 secretion through GPR120

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Leptin directly depolarizes preproglucagon neurons in the nucleus tractus solitarius: electrical properties of glucagon-like Peptide 1 neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

CCK stimulation of GLP-1 neurons involves α1-adrenoceptor-mediated increase in glutamatergic synaptic inputs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

EFFECT OF GLUCAGON ON FOOD INTAKE AND WEIGHT GAIN IN THE YOUNG RAT

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The Physiology of Glucagon-like Peptide 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Regulation of alpha-cell function by the beta-cell in isolated human and rat islets deprived of glucose: the "switch-off" hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

In situ electrophysiological examination of pancreatic α cells in the streptozotocin-induced diabetes model, revealing the cellular basis of glucagon hypersecretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Experimental challenges to targeting poorly characterized GPCRs: uncovering the therapeutic potential for free fatty acid receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon-like peptide-1 inhibits apoptosis of insulin-secreting cells via a cyclic 5'-adenosine monophosphate-dependent protein kinase A- and a phosphatidylinositol 3-kinase-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Divergent leptin signaling in proglucagon neurons of the nucleus of the solitary tract in mice and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Drug-drug interactions with glucagon-like peptide-1 receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon receptors on human islet cells contribute to glucose competence of insulin release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Dysfunction of lipid sensor GPR120 leads to obesity in both mouse and human

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Effect of intracerebroventricularly infused glucagon on feeding behavior.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Synergistic effect of portal glucose and glucagon-like peptide-1 to lower systemic glucose and stimulate counter-regulatory hormones.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Exenatide can reduce glucose independent of islet hormones or gastric emptying

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Changes in gastrointestinal hormone responses, insulin sensitivity, and beta-cell function within 2 weeks after gastric bypass in non-diabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Gut-expressed gustducin and taste receptors regulate secretion of glucagon-like peptide-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Transplantable rat glucagonomas cause acute onset of severe anorexia and adipsia despite highly elevated NPY mRNA levels in the hypothalamic arcuate nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Suppression of food intake by glucagon-like peptide-1 receptor agonists: relative potencies and role of dipeptidyl peptidase-4

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon and regulation of glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

GLP-1 action and glucose tolerance in subjects with remission of type 2 diabetes after gastric bypass surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Mechanisms underlying proglucagon gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Exaggerated glucagon-like peptide 1 response is important for improved β-cell function and glucose tolerance after Roux-en-Y gastric bypass in patients with type 2 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon-like peptide-1 evokes action potentials and increases cytosolic Ca2+ in rat nodose ganglion neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Gastrointestinal management of the bariatric surgery patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Bile acids promote glucagon-like peptide-1 secretion through TGR5 in a murine enteroendocrine cell line STC-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Insulin signaling in alpha cells modulates glucagon secretion in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Greater impact of melanocortin-4 receptor deficiency on rates of growth and risk of type 2 diabetes during childhood compared with adulthood in Pima Indians

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Disruption of the allosteric phosphorylase a regulation of the hepatic glycogen-targeted protein phosphatase 1 improves glucose tolerance in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Effects of Chronic Administration of Noradrenaline and Glucagon on In Vitro Brown Adipose Tissue Thermogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Intraislet production of GLP-1 by activation of prohormone convertase 1/3 in pancreatic α-cells in mouse models of ß-cell regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Association of variants in the PCSK1 gene with obesity in the EPIC-Norfolk study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The effects of GLP-1 infusion in the hepatic portal region on food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Nutrient-driven incretin secretion into intestinal lymph is different between diabetic Goto-Kakizaki rats and Wistar rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Endocrine pancreatic tumors with glucagon hypersecretion: a retrospective study of 23 cases during 20 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Brain glucagon-like peptide 1 signaling controls the onset of high-fat diet-induced insulin resistance and reduces energy expenditure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Role of central nervous system glucagon-like Peptide-1 receptors in enteric glucose sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon-like peptide-1 7-36: a physiological incretin in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Effects of central administration of glucagon on feed intake and endocrine responses in sheep

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Vagal afferents mediate early satiation and prevent flavour avoidance learning in response to intraperitoneally infused exendin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Diabetes remission after bariatric surgery: is it just the incretins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

GPR119 is required for physiological regulation of glucagon-like peptide-1 secretion but not for metabolic homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Contributions of gluconeogenesis to glucose production in the fasted state

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Hepatic handling of pancreatic glucagon and glucose during meals in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucose suppression of glucagon secretion: metabolic and calcium responses from alpha-cells in intact mouse pancreatic islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Hepatic portal infusion of glucagon antibodies increases spontaneous meal size in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Early milestones in glucagon research

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Ventromedial hypothalamic glucokinase is an important mediator of the counterregulatory response to insulin-induced hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon-like peptide-1 inhibits pancreatic ATP-sensitive potassium channels via a protein kinase A- and ADP-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Evidence for an important role of glucagon in the regulation of hepatic glucose production in normal man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon-like peptide-1 activation of TCF7L2-dependent Wnt signaling enhances pancreatic beta cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Preproglucagon (PPG) neurons innervate neurochemically identified autonomic neurons in the mouse brainstem

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Preproglucagon neurons project widely to autonomic control areas in the mouse brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Liver-specific disruption of the murine glucagon receptor produces α-cell hyperplasia: evidence for a circulating α-cell growth factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The glucagon receptor is required for the adaptive metabolic response to fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Incretin-based therapies for type 2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

A potent class of GPR40 full agonists engages the enteroinsular axis to promote glucose control in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Defective glucose-dependent insulinotropic polypeptide receptor expression in diabetic fatty Zucker rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon stimulates exocytosis in mouse and rat pancreatic alpha-cells by binding to glucagon receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

A K ATP channel-dependent pathway within alpha cells regulates glucagon release from both rodent and human islets of Langerhans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Metabolism and excretion of the once-daily human glucagon-like peptide-1 analog liraglutide in healthy male subjects and its in vitro degradation by dipeptidyl peptidase IV and neutral endopeptidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The major determinant of exendin-4/glucagon-like peptide 1 differential affinity at the rat glucagon-like peptide 1 receptor N-terminal domain is a hydrogen bond from SER-32 of exendin-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

GLP-1 receptor agonists today

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Bariatric surgery reduces mortality in Swedish men

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Basal receptor activation by locally produced glucagon-like peptide-1 contributes to maintaining beta-cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Activation of ATP-sensitive K+ channels in the ventromedial hypothalamus amplifies counterregulatory hormone responses to hypoglycemia in normal and recurrently hypoglycemic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucose dependence of the regulated secretory pathway in alphaTC1-6 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the intraislet insulin hypothesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Insulinotropin: glucagon-like peptide I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

High-fat diet changes the temporal profile of GLP-1 receptor-mediated hypophagia in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The antagonistic metabolite of GLP-1, GLP-1 (9-36)amide, does not influence gastric emptying and hunger sensations in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Secretion of glucagon-like peptide-1 (GLP-1) in type 2 diabetes: what is up, what is down?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Normalization of fasting hyperglycaemia by exogenous glucagon-like peptide 1 (7-36 amide) in type 2 (non-insulin-dependent) diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Regulation of pancreatic PC1 and PC2 associated with increased glucagon-like peptide 1 in diabetic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Regulation of glucagon receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Molecular mechanisms underlying nutrient-stimulated incretin secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Molecular mechanisms underlying bile acid-stimulated glucagon-like peptide-1 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glycemic control in mice with targeted disruption of the glucagon receptor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucose metabolism is altered after loss of L cells and α-cells but not influenced by loss of K cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Effects of a novel glucagon receptor antagonist (Bay 27-9955) on glucagon-stimulated glucose production in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The T allele of rs7903146 TCF7L2 is associated with impaired insulinotropic action of incretin hormones, reduced 24 h profiles of plasma insulin and glucagon, and increased hepatic glucose production in young healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon-like peptide 1/glucagon receptor dual agonism reverses obesity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Metabolism of glucagon by dipeptidyl peptidase IV (CD26).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Suppression of glucose production by GLP-1 independent of islet hormones: a novel extrapancreatic effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

GLP-1 receptor localization in monkey and human tissue: novel distribution revealed with extensively validated monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Differential effects of acute and extended infusions of glucagon-like peptide-1 on first- and second-phase insulin secretion in diabetic and nondiabetic humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

GLP-1 mediates antiapoptotic effect by phosphorylating Bad through a beta-arrestin 1-mediated ERK1/2 activation in pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Loss of the decrement in intraislet insulin plausibly explains loss of the glucagon response to hypoglycemia in insulin-deficient diabetes: documentation of the intraislet insulin hypothesis in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Maintenance of the postabsorptive plasma glucose concentration: insulin or insulin plus glucagon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Physiologic action of glucagon on liver glucose metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Membrane potential-dependent inactivation of voltage-gated ion channels in alpha-cells inhibits glucagon secretion from human islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucose-sensing in glucagon-like peptide-1-secreting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

A human cellular model for studying the regulation of glucagon-like peptide-1 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Identification and characterization of GLP-1 receptor-expressing cells using a new transgenic mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Role of the vagus nerve in mediating proximal nutrient-induced glucagon-like peptide-1 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Innervation patterns of autonomic axons in the human endocrine pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Regulation of calcium in pancreatic α- and β-cells in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Parasympathetic innervation and function of endocrine pancreas requires the glial cell line-derived factor family receptor alpha2 (GFRalpha2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Hindbrain GLP-1 receptor-mediated suppression of food intake requires a PI3K-dependent decrease in phosphorylation of membrane-bound Akt.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Emerging combinatorial hormone therapies for the treatment of obesity and T2DM.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Effect of endogenous GLP-1 on insulin secretion in type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The anorectic effect of GLP-1 in rats is nutrient dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Impaired glucagon-like peptide-1-induced insulin secretion in carriers of transcription factor 7-like 2 (TCF7L2) gene polymorphisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Bariatric surgery versus intensive medical therapy in obese patients with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Gastric emptying and release of incretin hormones after glucose ingestion in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Effect of glucagon on food intake and body weight in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

K(IR)6.2 polymorphism predisposes to type 2 diabetes by inducing overactivity of pancreatic beta-cell ATP-sensitive K(+) channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Leptin receptor expression in hindbrain Glp-1 neurons regulates food intake and energy balance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor -/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Cephalic-phase insulin and glucagon release in normal subjects and in patients receiving pancreas transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Direct effect of GLP-1 infusion on endogenous glucose production in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and beta-cell glucose competence

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Contribution of endogenous glucagon-like peptide 1 to glucose metabolism after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon receptor signaling is essential for control of murine hepatocyte survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Cephalic phase responses and appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The role of β cell glucagon-like peptide-1 signaling in glucose regulation and response to diabetes drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Adaptive reciprocity of lipid and glucose metabolism in human short-term starvation

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Beta-Arrestin-1 mediates glucagon-like peptide-1 signaling to insulin secretion in cultured pancreatic beta cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The glucagonoma syndrome: clinical features, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Pancreatic islet plasticity: interspecies comparison of islet architecture and composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Antidiabetic activity of a highly potent and selective nonpeptide somatostatin receptor subtype-2 agonist.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Metabolic effects of metformin in non-insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Phosphoenolpyruvate carboxykinase overexpression selectively attenuates insulin signaling and hepatic insulin sensitivity in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Minireview: The role of the autonomic nervous system in mediating the glucagon response to hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Coadministration of glucagon-like peptide-1 during glucagon infusion in humans results in increased energy expenditure and amelioration of hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Distribution of glucagon-like peptide-1 immunoreactivity in the hypothalamic paraventricular and supraoptic nuclei

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

How neural mediation of anticipatory and compensatory insulin release helps us tolerate food

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Brain glucose sensing and neural regulation of insulin and glucagon secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Ontogeny of regeneration of beta-cells in the neonatal rat after treatment with streptozotocin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Synaptic glutamate release by ventromedial hypothalamic neurons is part of the neurocircuitry that prevents hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Expression of the GLP-1 receptor in mouse, rat, and human pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

The prevalent Glu23Lys polymorphism in the potassium inward rectifier 6.2 (KIR6.2) gene is associated with impaired glucagon suppression in response to hyperglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Proglucagon processing in islet and intestinal cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

A role for glucagon-like peptide-1 in the central regulation of feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Physiology and pathophysiology of glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Radioimmunoassay of glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon physiology and pathophysiology in the light of new advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Bile acids have the gall to function as hormones

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Pancreatic glucagon, food deprivation and feeding in intact and vagotomized rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Effects of sitagliptin and metformin treatment on incretin hormone and insulin secretory responses to oral and "isoglycemic" intravenous glucose

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon-induced acetylation of Foxa2 regulates hepatic lipid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Long-term effects of Roux-en-Y gastric bypass surgery on plasma glucagon-like peptide-1 and islet function in morbidly obese subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

TCF7L2 variant rs7903146 affects the risk of type 2 diabetes by modulating incretin action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Effects of glucagon-like peptide-1 receptor agonists on weight loss: systematic review and meta-analyses of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Characterization of brainstem preproglucagon projections to the paraventricular and dorsomedial hypothalamic nuclei.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Gastric distension induces c-Fos in medullary GLP-1/2-containing neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Splanchnic regulation of glucose production

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Exenatide reduces food intake and activates the enteric nervous system of the gastrointestinal tract and the dorsal vagal complex of the hindbrain in the rat by a GLP-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Interactions between glucagon and other counterregulatory hormones during normoglycemic and hypoglycemic exercise in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Lesion of vagal afferent terminals impairs glucagon-induced suppression of food intake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucagon replacement via micro-osmotic pump corrects hypoglycemia and alpha-cell hyperplasia in prohormone convertase 2 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Altered proglucagon processing in an alpha-cell line derived from prohormone convertase 2 null mouse islets

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Truncated GLP-1 (proglucagon 78-107-amide) inhibits gastric and pancreatic functions in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Regulation of GIP and GLP1 receptor cell surface expression by N-glycosylation and receptor heteromerization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Improving function and survival of pancreatic islets by endogenous production of glucagon-like peptide 1 (GLP-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Wnt signaling: is the party in the nucleus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Leptin regulation of the anorexic response to glucagon-like peptide-1 receptor stimulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Different transcription factor binding arrays modulate the cAMP responsivity of the phosphoenolpyruvate carboxykinase gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Expression pattern of IAPP and prohormone convertase 1/3 reveals a distinctive set of endocrine cells in the embryonic pancreas

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Vertical sleeve gastrectomy is effective in two genetic mouse models of glucagon-like Peptide 1 receptor deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Insulin secretion from human beta cells is heterogeneous and dependent on cell-to-cell contacts

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Insulin regulates the activity of forkhead transcription factor Hnf-3beta/Foxa-2 by Akt-mediated phosphorylation and nuclear/cytosolic localization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

A whole-body model for glycogen regulation reveals a critical role for substrate cycling in maintaining blood glucose homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

GLP-1 receptor signaling is not required for reduced body weight after RYGB in rodents

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Cross talk between the insulin and Wnt signaling pathways: evidence from intestinal endocrine L cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Stimulation of incretin secretion by dietary lipid: is it dose dependent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Pancreatic α-cell hyperplasia: facts and myths

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

New insights into the role of cAMP in the production and function of the incretin hormone glucagon-like peptide-1 (GLP-1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Foxa2 integrates the transcriptional response of the hepatocyte to fasting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Hindbrain leptin and glucagon-like-peptide-1 receptor signaling interact to suppress food intake in an additive manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Glucose prevents the fall in ventromedial hypothalamic GABA that is required for full activation of glucose counterregulatory responses during hypoglycemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Fast pouch emptying, delayed small intestinal transit, and exaggerated gut hormone responses after Roux-en-Y gastric bypass

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression1This work was supported by a grant from the Crohn's and Colitis Foundation of America.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Effects of glucagon-like peptide 1 (7-36 amide) on whole-body protein metabolism in healthy man

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Physiological and Pharmacological Mechanisms through which the DPP-4 Inhibitor Sitagliptin Regulates Glycemia in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014

Calorigenic Action of Glucagon

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FPHYSREV.00013.2014